SEC Info - Yijia Group Corp. - ‘10-Q’ for 1/31/24

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Condensed Consolidated Balance Sheets as of January 31, 2024 (Unaudited) and April 30, 2023 (Audited) Condensed Consolidated Statements of Cash Flows for the Six Months ended January 31, 2024 and 2023 (Unaudited) Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the Nine Months Ended January 31, 2024 and 2023 (Unaudited) Condensed Consolidated Statements of Operations for the Three and Nine Months ended January 31, 2024 and 2023 (Unaudited) Controls and Procedures Defaults Upon Senior Securities Exhibits Financial Information Financial Statements (Unaudited) Legal Proceedings Management's Discussion and Analysis of Financial Condition and Results of Operations Mine Safety Disclosures Notes to the Condensed Consolidated Financial Statements (Unaudited) Other Information Quantitative and Qualitative Disclosures About Market Risk Risk Factors Signatures Table of Contents Unregistered Sales of Equity Securities and Use of Proceeds
1	1st Page – Filing Submission
"	Table of Contents
"	Financial Information
"	Financial Statements (Unaudited)
"	Condensed Consolidated Balance Sheets as of January 31, 2024 (Unaudited) and April 30, 2023 (Audited)
"	Condensed Consolidated Statements of Operations for the Three and Nine Months ended January 31, 2024 and 2023 (Unaudited)
"	Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the Nine Months Ended January 31, 2024 and 2023 (Unaudited)
"	Condensed Consolidated Statements of Cash Flows for the Six Months ended January 31, 2024 and 2023 (Unaudited)
"	Notes to the Condensed Consolidated Financial Statements (Unaudited)
"	Management's Discussion and Analysis of Financial Condition and Results of Operations
"	Quantitative and Qualitative Disclosures About Market Risk
"	Controls and Procedures
"	Other Information
"	Legal Proceedings
"	Risk Factors
"	Unregistered Sales of Equity Securities and Use of Proceeds
"	Defaults Upon Senior Securities
"	Mine Safety Disclosures
"	Exhibits
"	Signatures

i false i --04-30 i 2024 i Q3 i 0001699709 i i i i i i i i i i i i i i i 0001699709 2023-05-01 2024-01-31 0001699709 2024-03-06 0001699709 2024-01-31 0001699709 2023-04-30 0001699709 2023-11-01 2024-01-31 0001699709 2022-11-01 2023-01-31 0001699709 2022-05-01 2023-01-31 0001699709 us-gaap:CommonStockMember 2023-04-30 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001699709 us-gaap:RetainedEarningsMember 2023-04-30 0001699709 us-gaap:CommonStockMember 2023-07-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001699709 us-gaap:RetainedEarningsMember 2023-07-31 0001699709 2023-07-31 0001699709 us-gaap:CommonStockMember 2023-10-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001699709 us-gaap:RetainedEarningsMember 2023-10-31 0001699709 2023-10-31 0001699709 us-gaap:CommonStockMember 2022-04-30 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001699709 us-gaap:RetainedEarningsMember 2022-04-30 0001699709 2022-04-30 0001699709 us-gaap:CommonStockMember 2022-07-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001699709 us-gaap:RetainedEarningsMember 2022-07-31 0001699709 2022-07-31 0001699709 us-gaap:CommonStockMember 2022-10-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001699709 us-gaap:RetainedEarningsMember 2022-10-31 0001699709 2022-10-31 0001699709 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001699709 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001699709 2023-05-01 2023-07-31 0001699709 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001699709 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001699709 2023-08-01 2023-10-31 0001699709 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0001699709 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001699709 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001699709 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001699709 2022-05-01 2022-07-31 0001699709 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001699709 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001699709 2022-08-01 2022-10-31 0001699709 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001699709 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001699709 us-gaap:CommonStockMember 2024-01-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001699709 us-gaap:RetainedEarningsMember 2024-01-31 0001699709 us-gaap:CommonStockMember 2023-01-31 0001699709 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001699709 us-gaap:RetainedEarningsMember 2023-01-31 0001699709 2023-01-31 0001699709 YJGJ:CaihongQuMember 2023-09-12 0001699709 us-gaap:PrivatePlacementMember 2023-11-01 2024-01-31 0001699709 YJGJ:NutripeakTradingCorporationMember 2023-05-01 2024-01-31 0001699709 YJGJ:NutripeakTradingCorporationMember 2024-01-31 0001699709 us-gaap:PrivatePlacementMember 2024-01-31 0001699709 2024-12-31 0001699709 2023-04-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

i ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

i ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). i Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and, “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ i No ☒

The number of shares of the issuer’s common stock issued and outstanding was i 25,012,270, as of March 6, 2024.

The accompanying interim consolidated financial statements of Yijia Group Corp. (“the Company” or “YJGJ”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations.

The interim consolidated financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements.

In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

(Currency expressed in United States Dollars (“US$”), except for number of shares)

See accompanying notes, which are an integral part of these condensed consolidated financial statements.

(Currency expressed in United States Dollars (“US$”), except for number of shares)

See accompanying notes, which are an integral part of these condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

See accompanying notes, which are an integral part of these condensed consolidated financial statements.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our results of operations and financial condition should be read together with our unaudited condensed consolidated financial statements and the notes thereto, which are included elsewhere in this report and our Annual Report on Form 10-K for the fiscal year ended April 30, 2023 (the “Annual Report”) filed with SEC. Our financial statements have been prepared in accordance with U.S. GAAP. In addition, our financial statements and the financial information included in this report reflect our organizational transactions and have been prepared as if our current corporate structure had been in place throughout the relevant periods.

Statements made in this Form 10-Q that are not historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Financial information contained in this report and in our financial statements is stated in United States dollars and are prepared in accordance with United States generally accepted accounting principles.

The Company was incorporated as Soldino Group Corp. on January 25, 2017 under the laws of the State of Nevada, United States of America. On November 15, 2018, the Company changed its name to Yijia Group Corp. The Company is in good standing in the State of Nevada and in any jurisdiction where it is qualified to do business.

The Company currently engages in the rendering of business consulting service to domestic and international customers. The Company provides consulting services to its clients with regards to funding and other financial matters.

On June 6, 2023, the Company’s major shareholder and director, Barry Sytner entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Xianchang Ma (“Mr. Ma”), pursuant to which Barry Sytner sold 5,066,250 shares of common stock of the Company to Mr. Ma, constituting approximately 86.3% of the issued and outstanding shares of the Company as of May 2, 2023, for a total consideration of $470,562, derived from the purchaser’s personal funds. The Securities Purchase Agreement was closed on June 14, 2023. Following the closing, Mr. Ma acquired a beneficial interest in 5,066,250 shares of common stock of the Company constituting approximately 86.3% of the issued and outstanding shares of the Company as of May 2, 2023 and constituting the change of control of the Company. Pursuant to the Securities Purchase Agreement, Barry Sytner has resigned from all his positions with the Company, and Mr. Ma was appointed as the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, effective from June 14, 2023.

Mr. Ma passed away on August 3, 2023. On September 12, 2023, Ms. Caihong Qu, Mr. Xianchang Ma’s sole heir, was allocated 5,066,250 shares of the Company’s common stock at a consideration of $0 through operation of law. Upon completion of this transfer, Ms. Qu possessed 5,066,250 shares of common stock of the Company, constituting approximately 86.3% of the issued and outstanding shares of the Company as of September 12, 2023 and constituting control of the Company at that time. Effective September 13, 2023, the Board comprised Ms. Qiuping Lu and Mr. Ruiming Zhou. Ms. Qiuping Lu was appointed as the Chief Executive Officer, President, and Chief Financial Officer of the Company.

On November 9, 2023, the Company founded Nutripeak Trading Corporation (“NTC”), a wholly owned subsidiary incorporated in Nevada. NTC was established with the purpose of manufacturing and marketing healthcare products.

On January 30, 2024, the Company entered into ten securities purchase agreements (the “Purchase Agreements”) in connection with its private offering (the “Offering”) of the Company’s unregistered shares of common stock, par value $0.001, with a total of ten (10) investors, consisting of two (2) U.S. accredited investors, as defined under Rule 501 of Regulation D, and eight (8) non-U.S. investors (individually, an “Investor” and collectively, the “Investors”), at a purchase price of $0.05 per share. This Offering was being conducted on a rolling basis and there was no minimum nor maximum offering amount to close this Offering. Each of the Purchase Agreements contained customary representations, warranties and covenants by the parties, regularly applied under industry standards. Each of the Investors acknowledged and agreed that any resale of the shares issued in connection with this Offering is subject to resale restrictions pursuant to the Securities Exchange Act of 1934 and none of the shares purchased herein has been registered under the Securities Act of 1933, as amended. This Offering was closed on January 30, 2024 and the Company raised an aggregate gross proceeds of $957,051 by selling and issuing 19,141,020 shares of its common stock in this Offering.

The Company generated revenues of $26,100 and $10,000 for the three months ended January 31, 2024 and 2023, respectively. Revenues increased in 2024 over 2023 by $16,100, or 161%, primarily due to increase in demand of its business consulting services.

The Company incurred general and administrative expenses of $20,152 and $34,577 for the three months ended January 31, 2024 and 2023, respectively. General and administrative expenses decreased in 2024 over 2023 by $14,425, or 42%, primarily due to decrease in marketing promotion expense.

As a result of the factors described above, for the three months ended January 31, 2024 and 2023, the Company has a net income of $5,948 and a net loss of $24,577, respectively.

The Company generated revenues of $26,100 and $35,000 for the nine months ended January 31, 2024 and 2023, respectively. Revenues decreased in 2024 over 2023 by $8,900, or 25%, primarily due to decrease in marketing promotion.

The Company incurred general and administrative expenses of $53,154 and $54,842 for the nine months ended January 31, 2024 and 2023, respectively. General and administrative expenses decreased in 2024 over 2023 by $1,688, or 3%, primarily due to decrease in marketing promotion expense mentioned above.

As a result of the factors described above, for the nine months ended January 31, 2024 and 2023, the Company has a net loss of $27,054 and $19,842, respectively.

On January 31, 2024, we had total current assets of $964,356, which consisted primarily of $808,356 in cash and cash equivalents and $156,000 in deposit and other receivables. We had total current liabilities of $93,574, which consisted of $43,372 due to related parties and $50,202 in accrued liabilities and other payables.

On April 30, 2023, we had total current assets of $8,728 which consist of $8,728 in cash and cash equivalents. We had total current liabilities of $67,943, which consist of $16,100 due to related parties and $51,843 in accrued liabilities and other payables.

For the nine months ended January 31, 2024, net cash flows used in operating activities was $184,695, which consisted primarily of a net loss of $27,054, an increase in deposit and other receivables of $156,000 and a decrease in accrued liabilities and other payables of $1,641.

For the nine months ended January 31, 2023, net cash flows used in operating activities was $16,090, which consisted primarily of a net loss of $19,482 and an increase in accrued liabilities and other payables of $3,752.

For the nine months ended January 31, 2024, net cash provided by financing activities was $984,323, which consisted primarily of procced from private offering of $957,051 and advances from related parties of $27,272.

For the nine months ended January 31, 2023, net cash provided by financing activities was $4,000 from proceeds from a related party.

As of January 31, 2024, we had no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2024. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (1) lack of a functioning audit committee due to a lack of a majority of independent members and a lack of a majority of outside directors on our Board of Directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; (2) inadequate segregation of duties consistent with control objectives; and (3) ineffective controls over period end financial disclosure and reporting processes. The aforementioned material weaknesses were identified by our Chief Executive Officer and Chief Financial Officer in connection with the review of our financial statements as of January 31, 2024.

Management believes that the material weaknesses set forth in items (2) and (3) above did not have an effect on our financial results. However, management believes that the lack of a functioning audit committee and the lack of a majority of outside directors on our Board of Directors results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future periods.

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We are aware that any system of controls, however well designed and operated, can only provide reasonable, and not absolute, assurance that the objectives of the system are met, and that maintenance of disclosure controls and procedures is an ongoing process that may change over time.

We are currently not a party to any legal proceedings, and we are not aware of any pending or potential legal actions.

The information to be reported under this Item is not required for smaller reporting companies.

During the quarter ended January 31, 2024, no director or officer i i adopted / or i i terminated / any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.

* This certification is deemed furnished, and not filed, for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized on March 11, 2024.

i Nevada	i 35-2583762
(State or Other Jurisdiction of Incorporation or Organization)	(IRS Employer Identification Number)

i 39 E Broadway, i Ste 603, i New York, i NY	i 10002
(Address of principal executive offices)	(Zip Code)

Title of each class		Name of each exchange on which registered
N/A		N/A

	January 31, 2024 (Unaudited)			April 30, 2023 (Audited)

ASSETS
Current assets:
Cash and cash equivalents	$	i 808,356		$	i 8,728
Deposit and other receivables		i 156,000			i –
Total Current Assets		i 964,356			i 8,728

TOTAL ASSETS	$	i 964,356		$	i 8,728

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Liabilities
Current Liabilities
Accrued liabilities and other payables	$	i 50,202		$	i 51,843
Amount due to related parties		i 43,372			i 16,100
Total Current Liabilities		i 93,574			i 67,943

Total Liabilities		i 93,574			i 67,943

Commitments and Contingencies		–			–

Stockholders’ Equity (Deficit)
Common stock, par value $ i i 0.001 / ; i i 75,000,000 / shares authorized, i i 25,012,270 / and i i 5,871,250 / shares issued and outstanding, respectively		i 25,012			i 5,871
Additional paid in capital		i 996,734			i 58,824
Accumulated deficit		( i 150,964	)		( i 123,910	)
Total Stockholders’ Equity (Deficit)		i 870,782			( i 59,215	)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	i 964,356		$	i 8,728


	For the three months ended January 31,						For the nine months ended January 31,
	2024			2023			2024			2023

REVENUE	$	i 26,100		$	i 10,000		$	i 26,100		$	i 35,000

OPERATING EXPENSES
General and Administrative Expenses		i 20,152			i 34,577			i 53,154			i 54,842
TOTAL OPERATING EXPENSES		( i 20,152	)		( i 34,577	)		( i 53,154	)		( i 54,842	)

INCOME (LOSS) BEFORE INCOME TAX		i 5,948			( i 24,577	)		( i 27,054	)		( i 19,842	)

PROVISION FOR INCOME TAXES		i –			i –			i –			i –

NET INCOME (LOSS)	$	i 5,948		$	( i 24,577	)	$	( i 27,054	)	$	( i 19,842	)

NET INCOME (LOSS) PER SHARE - BASIC AND DILUTED	$	i i 0.00 /		$	( i i 0.00 /	)	$	( i i 0.00 /	)	$	( i i 0.00 /	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED		i i 6,079,305 /			i i 5,871,250 /			i i 25,012,270 /			i i 5,871,250 /

	Nine months ended January 31, 2024			Nine months ended January 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	( i 27,054	)	$	( i 19,842	)
Changes in operating assets and liabilities:
Deposit and other receivables		( i 156,000	)		i –
Accrued liabilities and other payables		( i 1,641	)		i 3,752
NET CASH USED IN OPERATING ACTIVITIES		( i 184,695	)		( i 16,090	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from private offering		i 957,051			i –
Proceeds from related parties		i 27,272			i 4,000
NET CASH PROVIDED BY FINANCING ACTIVITIES		i 984,323			i 4,000

NET CHANGE IN CASH AND CASH EQUIVALENTS		i 799,628			( i 12,090	)

Cash and cash equivalents, beginning of period		i 8,728			i 23,103

Cash and cash equivalents, end of period	$	i 808,356		$	i 11,013

SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	i –		$	i –
Income taxes paid	$	i –		$	i –

Yijia Group Corp. – ‘10-Q’ for 1/31/24

On: Monday, 3/11/24, at 4:35pm ET · For: 1/31/24 · Accession #: 1683168-24-1418 · File #: 333-218733

Previous ‘10-Q’: ‘10-Q’ on 12/15/23 for 10/31/23 · Latest ‘10-Q’: This Filing

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Form10-Q for January 2024

Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

		Page
PART I	FINANCIAL INFORMATION:

Item 1.	Financial Statements (Unaudited)	3

	Condensed Consolidated Balance Sheets as of January 31, 2024 (Unaudited) and April 30, 2023 (Audited)	4

	Condensed Consolidated Statements of Operations for the Three and Nine Months ended January 31, 2024 and 2023 (Unaudited)	5

	Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the Nine Months Ended January 31, 2024 and 2023 (Unaudited)	6

	Condensed Consolidated Statements of Cash Flows for the Six Months ended January 31, 2024 and 2023 (Unaudited)	7

	Notes to the Condensed Consolidated Financial Statements (Unaudited)	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	16

Item 4.	Controls and Procedures	16

PART II	OTHER INFORMATION:

Item 1.	Legal Proceedings	17

Item 1A	Risk Factors	17

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	17

Item 3.	Defaults Upon Senior Securities	17

Item 4.	Mine Safety Disclosures	17

Item 5.	Other Information	17

Item 6.	Exhibits	17

	Signatures	18

Schedule of description of subsidiaries
Name	Place of incorporation and kind of legal entity	Principal activities and place of operation	Particulars of issued/ registered share capital	Effective interest Held

i Nutripeak Trading Corporation	i State of Nevada, United States of America, Corporation	i Manufacturing and marketing healthcare products	i 100 shares of common stock authorized, par value $1 per share	i 100%

·	identify the contract with a customer;
·	identify the performance obligations in the contract;
·	determine the transaction price;
·	allocate the transaction price to performance obligations in the contract; and
·	recognize revenue as the performance obligation is satisfied.

Level 1:	defined as observable inputs such as quoted prices in active markets;
Level 2:	defined as inputs other than quoted prices in active markets that are either directly or indirectly observable;
Level 3:	defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

Schedule of deferred taxes	As of January 31, 2024 (Unaudited)			As of April 30, 2023 (Audited)
Non-current deferred tax assets:
Net operating loss carryforward	$	( i 150,964	)	$	( i 123,910	)

Total deferred tax assets		( i 31,702	)		( i 26,021	)
Valuation allowance		i 31,702			i 26,021
Net deferred tax assets	$	i –		$	i –

	Three Months Ended January 31,
	2024			2023
Revenues	$	26,100		$	10,000
General and administrative expenses		(20,152	)		(34,577	)
Income (loss) from operation		5,948			(24,577	)
Income tax expense		–			–
Net income (loss)		5,948			(24,577	)

	Nine Months Ended January 31,
	2024			2023
Revenues	$	26,100		$	35,000
General and administrative expenses		(53,154	)		(54,842	)
Loss from operation		(27,054	)		(19,842	)
Income tax expense		–			–
Net loss		(27,054	)		(19,842	)

	Nine Months ended
	January 31, 2024			January 31, 2023
Net cash used in by operating activities	$	(184,695	)	$	(16,090	)
Net cash provided by investing activities		–			–
Net cash provided by financing activities		984,323			4,000

31.1	Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
31.2	Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
32.1*	Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted in inline XBRL, and included in exhibit 101).

This ‘10-Q’ Filing	Date	Other Filings

	4/30/24
Filed on:	3/11/24
	3/8/24
	3/6/24
For Period end:	1/31/24
	1/30/24	8-K
	1/8/24	8-K
	11/9/23
	10/31/23	10-Q
	9/13/23
	9/12/23	8-K
	8/3/23
	7/31/23	10-Q
	6/14/23	8-K
	6/6/23
	5/16/23
	5/2/23
	5/1/23
	4/30/23	10-K
	1/31/23	10-Q
	10/31/22	10-Q
	7/31/22	10-Q
	5/1/22
	11/15/18	8-K
	1/25/17
		List all Filings

Yijia Group Corp. – ‘10-Q’ for 1/31/24

On: Monday, 3/11/24, at 4:35pm ET · For: 1/31/24 · Accession #: 1683168-24-1418 · File #: 333-218733

Previous ‘10-Q’: ‘10-Q’ on 12/15/23 for 10/31/23 · Latest ‘10-Q’: This Filing

Quarterly Report — Form 10-QFiling Table of Contents

‘10-Q’ — Form10-Q for January 2024Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Form10-Q for January 2024

Document Table of Contents